Showing results (91-100 of 391) with videos related to
Sort By:
Pageof 40
The New England Journal of Medicine|October 19, 2017
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF InhibitorsDafna Gladman, William Rigby, Valderilio F Azevedo, et al.Journal of Clinical Medicine|March 25, 2022
Advances in the Treatment of Giant Cell ArteritisSantos Castañeda, Diana Prieto-Peña, Esther F Vicente-Rabaneda, et al.Rheumatology and Therapy|March 18, 2024
Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARERoy Fleischmann, Ricardo Blanco, Filip Van den Bosch, et al.The Lancet. Rheumatology|January 26, 2024
5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trialHelena Marzo-Ortega, Joachim Sieper, Alan J Kivitz, et al.Seminars in Arthritis and Rheumatism|November 11, 2025
Tocilizumab monotherapy versus combined in aortitis associated with giant cell arteritis: Factors associated with imaging remission in a multicenter open-label study of 196 patientsAdrián Martín-Gutiérrez, Javier Loricera, Diana Prieto-Peña, et al.ACR Open Rheumatology|January 21, 2020
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 StudyKarel Pavelka, Alan J Kivitz, Eva Dokoupilova, et al.Seminars in Arthritis and Rheumatism|March 26, 2026
Is there a window of opportunity in the treatment of giant cell arteritis with tocilizumab? Multicenter study of 471 patientsAdrián Martín-Gutiérrez, Javier Loricera, Diana Prieto-Peña, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2020
Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator-Controlled TrialRonald van Vollenhoven, Tsutomu Takeuchi, Aileen L Pangan, et al.Medicine|November 14, 2009
The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular diseaseCarlos Gonzalez-Juanatey, Tomas R Vazquez-Rodriguez, Jose A Miranda-Filloy, et al.Clinical and Experimental Rheumatology|August 1, 2013
Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritisRaquel López-Mejías, Alfonso Corrales, Fernanda Genre, et al.Pageof 40